CALYPTE BIOMEDICAL CORP Deferred Revenue
CALYPTE BIOMEDICAL CORP had Deferred Revenue of $23.00 thousand as of 2010-12-31, per its 10-K filed 2012-03-22.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2012-03-22
- 2010-12-31: Deferred Revenue, Current $23.00K.
| Period end | Deferred Revenue, Current |
|---|---|
| 2010-12-31 | $23.00K 10-K · filed 2012-03-22 |